Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sun Pharmaceutical
Pharma
BIO-WuXi, Takeda, FDA-Carvykti—Fierce Pharma Asia
WuXi AppTec left BIO amid alleged biosecurity concerns. Takeda will close a gene therapy plant. The FDA flagged early deaths in a Carvykti trial.
Angus Liu
Mar 15, 2024 10:15am
Sun Pharma issues recall of gout drug due to contamination
Mar 11, 2024 10:54am
Sun Pharma picks Dr. Pimple Popper to open up acne talk
Mar 6, 2024 12:17pm
Pfizer quells 12 years of Lipitor antitrust litigation with $93M
Feb 15, 2024 11:11am
Roche, Daiichi-Seagen, LegoChem—Fierce Pharma Asia
Jan 19, 2024 8:48am
After 17-year courtship, Sun and Taro agree on $348M buyout
Jan 18, 2024 11:23am